DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Dexamethasone; tobramycinis the generic ingredient in three branded drugs marketed by Novartis, Eyevance, Amneal, and Bausch And Lomb, and is included in five NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are thirty-nine drug master file entries for dexamethasone; tobramycin. Eight suppliers are listed for this compound.
Recent Clinical Trials for dexamethasone; tobramycin
Identify potential brand extensions & 505(b)(2) entrants
|Sutphin Drugs||Early Phase 1|
|NTC srl||Phase 3|
|Athinaiki General Clinic||N/A|